Literature DB >> 11697890

Functional conservation of 14-3-3 isoforms in inhibiting bad-induced apoptosis.

R R Subramanian1, S C Masters, H Zhang, H Fu.   

Abstract

14-3-3 proteins are a family of homologous eukaryotic molecules with seven distinct isoforms in mammalian cells. Isoforms of 14-3-3 proteins interact with diverse ligands and are involved in the regulation of mitogenesis, cell cycle progression, and apoptosis. However, whether different 14-3-3 isoforms are responsible for distinct functions remains elusive. Here we report that multiple isoforms of 14-3-3 proteins were capable of binding to several ligands, Bad, Raf-1, and Cbl. In a functional assay of 14-3-3 isoforms, all mammalian 14-3-3 isoforms could inhibit Bad-induced apoptosis. Thus, 14-3-3 function in regulating one of its ligands, Bad, is conserved among mammalian isoforms. We addressed whether 14-3-3 isoforms are differentially expressed in tissues, which may in part determine isoform-specific interactions. In situ hybridization revealed that 14-3-3zeta was present in most tissues tested, but sigma was preferentially expressed in epithelial cells. Thus, isoforms of 14-3-3 can interact and control the function of selected protein ligands, and differential tissue distribution of 14-3-3 isoforms may contribute to their specific interactions and subsequent downstream signaling events. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11697890     DOI: 10.1006/excr.2001.5376

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  29 in total

1.  14-3-3σ Contributes to Radioresistance By Regulating DNA Repair and Cell Cycle via PARP1 and CHK2.

Authors:  Yifan Chen; Zhaomin Li; Zizheng Dong; Jenny Beebe; Ke Yang; Liwu Fu; Jian-Ting Zhang
Journal:  Mol Cancer Res       Date:  2017-01-13       Impact factor: 5.852

2.  Isoform-specific subcellular localization among 14-3-3 proteins in Arabidopsis seems to be driven by client interactions.

Authors:  Anna-Lisa Paul; Paul C Sehnke; Robert J Ferl
Journal:  Mol Biol Cell       Date:  2005-01-19       Impact factor: 4.138

3.  DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism.

Authors:  Sripathi M Sureban; Randal May; Stan A Lightfoot; Aimee B Hoskins; Megan Lerner; Daniel J Brackett; Russell G Postier; Rama Ramanujam; Altaf Mohammed; Chinthalapally V Rao; James H Wyche; Shrikant Anant; Courtney W Houchen
Journal:  Cancer Res       Date:  2011-02-01       Impact factor: 12.701

Review 4.  Growth factor signalling in endocrine and anti-growth factor resistant breast cancer.

Authors:  R I Nicholson; I R Hutcheson; H E Jones; S E Hiscox; M Giles; K M Taylor; J M W Gee
Journal:  Rev Endocr Metab Disord       Date:  2007-09       Impact factor: 6.514

5.  Immunocytochemical detection of 14-3-3 in primary nervous system tumors.

Authors:  Wei-Dong Cao; Xiang Zhang; Jian-Ning Zhang; Zhi-Jun Yang; Hai-Ning Zhen; Guang Cheng; Bian Li; Dakuan Gao
Journal:  J Neurooncol       Date:  2005-11-15       Impact factor: 4.130

Review 6.  14-3-3ζ as a prognostic marker and therapeutic target for cancer.

Authors:  Christopher L Neal; Dihua Yu
Journal:  Expert Opin Ther Targets       Date:  2010-12       Impact factor: 6.902

7.  Reversible epigenetic regulation of 14-3-3σ expression in acquired gemcitabine resistance by uhrf1 and DNA methyltransferase 1.

Authors:  Li Qin; Zizheng Dong; Jian-Ting Zhang
Journal:  Mol Pharmacol       Date:  2014-09-04       Impact factor: 4.436

8.  14-3-3sigma, the double-edged sword of human cancers.

Authors:  Zhaomin Li; Jing-Yuan Liu; Jian-Ting Zhang
Journal:  Am J Transl Res       Date:  2009-06-08       Impact factor: 4.060

9.  14-3-3 proteins are essential signalling hubs for beta cell survival.

Authors:  G E Lim; M Piske; J D Johnson
Journal:  Diabetologia       Date:  2013-01-26       Impact factor: 10.122

Review 10.  Epigenetic DNA hypermethylation in cholangiocarcinoma: potential roles in pathogenesis, diagnosis and identification of treatment targets.

Authors:  Dalbir S Sandhu; Abdirashid M Shire; Lewis R Roberts
Journal:  Liver Int       Date:  2007-11-21       Impact factor: 5.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.